Skip to main content
Top
Published in: BMC Gastroenterology 1/2009

Open Access 01-12-2009 | Research article

A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice

Authors: Bo Feng, Sheng Ming Wu, Sa Lv, Feng Liu, Hong Song Chen, Yan Gao, Fang Ting Dong, Lai Wei

Published in: BMC Gastroenterology | Issue 1/2009

Login to get access

Abstract

Background

It is frequently important to identify the prognosis of fulminant hepatic failure (FHF) patients as this will influence patient management and candidacy for liver transplantation. Therefore, a novel scoring system based on metabonomics combining with multivariate logistic regression was developed to predict the prognosis of FHF mouse model.

Methods

BALB/c mice were used to construct FHF model. Parts of plasma were collected at 4, 5, and 6-h time points after treatment, respectively, and detected using gas chromatography/time-of-flight mass spectrometry (GC/TOFMS). The acquired data were processed using partial least square discriminant analysis (PLS-DA). The metabolic markers identified were used to construct a scoring system by multivariate regression analysis.

Results

28 mice of survival group and 28 of dead group were randomly selected and analyzed. PLS regression analysis showed that both the PLS models of 5 h and 6 h after d-galactosamine/lipopolysaccharide treatment demonstrated good performances. Loadings plot suggested that phosphate, beta-hydroxybutyrate (HB), urea, glucose and lactate concentrations in plasma had the highest weightings on the clustering differences at the three time points. By the multivariate logistic regression analysis, the death/survival index (DSI) was constructed based on relative concentrations of HB, urea and phosphate. It provided general accurate rate of prediction of 93.3% in the independent samples.

Conclusions

The novel scoring system based on metabonomics combining with multivariate logistic regression is accurate in predicting the prognosis of FHF mouse model and may be referred in clinical practice as a more useful prognostic tool with other available information.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shakil AO, Mazariegos GV, Kramer DJ: Fulminant hepatic failure. Surg Clin North Am. 1999, 79: 77-108. 10.1016/S0039-6109(05)70008-6.CrossRefPubMed Shakil AO, Mazariegos GV, Kramer DJ: Fulminant hepatic failure. Surg Clin North Am. 1999, 79: 77-108. 10.1016/S0039-6109(05)70008-6.CrossRefPubMed
2.
go back to reference Polson J, Lee WM: AASLD position paper: the management of acute liver failure. Hepatology. 2005, 41: 1179-1197. 10.1002/hep.20703.CrossRefPubMed Polson J, Lee WM: AASLD position paper: the management of acute liver failure. Hepatology. 2005, 41: 1179-1197. 10.1002/hep.20703.CrossRefPubMed
3.
go back to reference Barba I, Chatauret N, Garcia-Dorado D, Cordoba J: A 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats. Liver Int. 2008, 28: 1141-1148. 10.1111/j.1478-3231.2008.01801.x.CrossRefPubMed Barba I, Chatauret N, Garcia-Dorado D, Cordoba J: A 1H nuclear magnetic resonance-based metabonomic approach for grading hepatic encephalopathy and monitoring the effects of therapeutic hypothermia in rats. Liver Int. 2008, 28: 1141-1148. 10.1111/j.1478-3231.2008.01801.x.CrossRefPubMed
4.
go back to reference Chung PY, Sitrin MD, Te HS: Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl. 2003, 9: 248-253. 10.1053/jlts.2003.50053.CrossRefPubMed Chung PY, Sitrin MD, Te HS: Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl. 2003, 9: 248-253. 10.1053/jlts.2003.50053.CrossRefPubMed
5.
go back to reference MacQuillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N: Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl. 2005, 11: 1073-1079. 10.1002/lt.20427.CrossRefPubMed MacQuillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N: Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl. 2005, 11: 1073-1079. 10.1002/lt.20427.CrossRefPubMed
6.
go back to reference Shakil AO: Predicting the outcome of fulminant hepatic failure. Liver Transpl. 2005, 11: 1028-1030. 10.1002/lt.20478.CrossRefPubMed Shakil AO: Predicting the outcome of fulminant hepatic failure. Liver Transpl. 2005, 11: 1028-1030. 10.1002/lt.20478.CrossRefPubMed
7.
go back to reference Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J: Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000, 6: 163-169.PubMed Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J: Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000, 6: 163-169.PubMed
8.
go back to reference Schmidt LE, Larsen FS: MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007, 45: 789-796. 10.1002/hep.21503.CrossRefPubMed Schmidt LE, Larsen FS: MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007, 45: 789-796. 10.1002/hep.21503.CrossRefPubMed
9.
go back to reference Barba I, de Leon Gustavo, Martin E, Cuevas A, Aquade S, Candell-Riera J, Barrabes JA, Garcia-Dorado D: Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med. 2008, 60: 27-32. 10.1002/mrm.21632.CrossRefPubMed Barba I, de Leon Gustavo, Martin E, Cuevas A, Aquade S, Candell-Riera J, Barrabes JA, Garcia-Dorado D: Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med. 2008, 60: 27-32. 10.1002/mrm.21632.CrossRefPubMed
10.
go back to reference Serkova NJ, Gamito EJ, Jones RH, O'Donnell C, Brown JL, Green S, Sullivan H, Hedlund T, Crawford ED: The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate. 2008, 68: 620-628. 10.1002/pros.20727.CrossRefPubMed Serkova NJ, Gamito EJ, Jones RH, O'Donnell C, Brown JL, Green S, Sullivan H, Hedlund T, Crawford ED: The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions. Prostate. 2008, 68: 620-628. 10.1002/pros.20727.CrossRefPubMed
11.
go back to reference Gottschalk M, Ivanova G, Collins DM, Eustace A, O'Connor R, Brougham DF: Metabolomic studies of human lung carcinoma cell lines using in vitro 1H NMR of whole cells and cellular extracts. NMR Biomed. 2008, 21: 809-819. 10.1002/nbm.1258.CrossRefPubMed Gottschalk M, Ivanova G, Collins DM, Eustace A, O'Connor R, Brougham DF: Metabolomic studies of human lung carcinoma cell lines using in vitro 1H NMR of whole cells and cellular extracts. NMR Biomed. 2008, 21: 809-819. 10.1002/nbm.1258.CrossRefPubMed
12.
go back to reference Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, Li Y, Dong F, Wei L: Metabolic profiling analysis of a d-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res. 2007, 6: 2161-2167. 10.1021/pr0606326.CrossRefPubMed Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, Li Y, Dong F, Wei L: Metabolic profiling analysis of a d-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res. 2007, 6: 2161-2167. 10.1021/pr0606326.CrossRefPubMed
13.
go back to reference Feng B, Wu S, Lv S, Fang J, Liu F, Li Y, Gao Y, Yan X, Dong F, Wei L: Dynamic metabonomic analysis of BALB/c mice with different outcomes after d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Liver Transpl. 2008, 14: 1620-1631. 10.1002/lt.21578.CrossRefPubMed Feng B, Wu S, Lv S, Fang J, Liu F, Li Y, Gao Y, Yan X, Dong F, Wei L: Dynamic metabonomic analysis of BALB/c mice with different outcomes after d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Liver Transpl. 2008, 14: 1620-1631. 10.1002/lt.21578.CrossRefPubMed
14.
go back to reference Pasikanti KK, Ho PC, Chan ECY: Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites. Rapid Commun. Mass Spectrom. 2008, 22: 2984-2992. Pasikanti KK, Ho PC, Chan ECY: Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites. Rapid Commun. Mass Spectrom. 2008, 22: 2984-2992.
15.
go back to reference Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET: Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008, 21: 195-207. 10.1002/nbm.1176.CrossRefPubMed Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET: Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008, 21: 195-207. 10.1002/nbm.1176.CrossRefPubMed
16.
go back to reference Bedair M, Sumner LW: Current and emerging mass spectrometry technologies for metabolomics. Trends Analyt Chem. 2008, 27: 238-250. 10.1016/j.trac.2008.01.006.CrossRef Bedair M, Sumner LW: Current and emerging mass spectrometry technologies for metabolomics. Trends Analyt Chem. 2008, 27: 238-250. 10.1016/j.trac.2008.01.006.CrossRef
17.
go back to reference Li X, Cristina LQ: Advances in separation science applied to metabonomics. Electrophoresis. 2008, 29: 3724-3736. 10.1002/elps.200700851.CrossRef Li X, Cristina LQ: Advances in separation science applied to metabonomics. Electrophoresis. 2008, 29: 3724-3736. 10.1002/elps.200700851.CrossRef
18.
go back to reference Lu Y, A J, Wang G, Hao H, Huang Q, Yan B, Zha W, Gu S, Ren H, Zhang Y, Fan X, Zhang M, Hao K: Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats. Rapid Commun Mass Spectrom. 2008, 22: 2882-2888. 10.1002/rcm.3670.CrossRefPubMed Lu Y, A J, Wang G, Hao H, Huang Q, Yan B, Zha W, Gu S, Ren H, Zhang Y, Fan X, Zhang M, Hao K: Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats. Rapid Commun Mass Spectrom. 2008, 22: 2882-2888. 10.1002/rcm.3670.CrossRefPubMed
Metadata
Title
A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice
Authors
Bo Feng
Sheng Ming Wu
Sa Lv
Feng Liu
Hong Song Chen
Yan Gao
Fang Ting Dong
Lai Wei
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2009
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-9-99

Other articles of this Issue 1/2009

BMC Gastroenterology 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.